Atlas Arteria (ALX) investor relations material

Opening remarks and agenda

• Meetings held as hybrid events for both Atlas Arteria Limited (ATLAX) and Atlas Arteria International Limited (ATLIX), with security holders attending in person and online.

• Chairs Debbie Goodin (ATLAX) and Fiona Beck (ATLIX) presided, with all directors and key executives introduced.

• Voting on all resolutions conducted by poll, with proxy positions released prior to the meeting.

Financial performance review

• 2025 saw steady traffic performance and toll revenue growth across all businesses, with proportional EBITDA up 9.3% year-on-year.

• Distributions of AUD 0.40 per security delivered in line with guidance, despite the impact of the French temporary supplementary tax (TST).

• 2026 distribution guidance maintained at AUD 0.40 per security, subject to business performance and external factors.

• Q1 2026 showed limited macroeconomic impact, with toll revenue up 0.1% (1.6% including FX), and continued growth in Virginia.

Board and executive committee updates

• Several directors stood for re-election, with all receiving unanimous board support except for abstentions by IFM as a shareholder.

• Chair Debbie Goodin confirmed this is her final re-election, with an orderly succession process underway.

• Board composition includes independent, nominee, and executive directors, with a majority of independent non-executives.